| Name: | Bicalutamide Oxirane Impurity |
| Catalogue No. | VE006823 |
| CAS No. | 90357-51-0 |
| Molecular Formula | C12H9F3N2O2 |
| Molecular Weight | 270.21 |
| Status | In-stock |
| IUPAC Name | N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide |
| Description | Bicalutamide Oxirane Impurity ( CAS No: 90357-51-0 ) or N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide is associate impurity Bicalutamide. Bicalutamide is used together with a luteinizing hormone releasing hormone (LHRH) analog (eg, goserelin or leuprolide) to treat stage D2 metastatic prostate cancer (cancer that has spread) in men. Bicalutamide belongs to the group of medicines called antiandrogens. It works by blocking the effects of testosterone (a male hormone), which h |
| References | “Sci-Hub | Structural Basis for Antagonism and Resistance of Bicalutamide in Prostate Cancer | 10.1073/Pnas.0500381102.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1073/pnas.0500381102. |
